Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
In consultation
In consultation: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (13 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Consultation end date
Consultation end date
From date
To date
Apply date filters
Type
(
3 selected
)
Type
Guidance (12)
NICE advice (0)
Quality standard (0)
Guidance programme
(
10 selected
)
Guidance programme
Cancer service guidelines (0)
Clinical guidelines (1)
Diagnostics guidance (0)
Health technology evaluations (1)
Highly specialised technologies guidance (1)
Interventional procedures guidance (5)
Medical technologies guidance (0)
Medicines practice guidelines (0)
NICE guidelines (1)
Quality standard (2)
Safe staffing guidelines (0)
Social care guidelines (0)
Technology appraisal guidance (5)
Apply filters
Showing 1 to 10 of 12
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Type: NICE advice
Remove Type: NICE advice filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Interventional procedures guidance
Remove Guidance programme: Interventional procedures guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Clinical guidelines
Remove Guidance programme: Clinical guidelines filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Cancer service guidelines
Remove Guidance programme: Cancer service guidelines filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Medicines practice guidelines
Remove Guidance programme: Medicines practice guidelines filter
Guidance programme: Safe staffing guidelines
Remove Guidance programme: Safe staffing guidelines filter
Guidance programme: Social care guidelines
Remove Guidance programme: Social care guidelines filter
Guidance and quality standards in consultation
Title
Consultation
Type
Consultation end date
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention
Interventional procedure consultation
Interventional procedures guidance
7 October 2024
Pegzilarginase for treating arginase-1 deficiency [ID4029]
Evaluation consultation
Highly specialised technology
27 September 2024
Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma [ID5123]
Draft guidance
Technology appraisal guidance
27 September 2024
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension
Interventional procedure consultation
Interventional procedures guidance
26 September 2024
Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder
Interventional procedure consultation
Interventional procedures guidance
26 September 2024
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis
Interventional procedure consultation
Interventional procedures guidance
26 September 2024
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis (Review of TA756) [ID5115]
Draft guidance
Technology appraisal guidance
26 September 2024
Lymphoedema: prevention and management in people with early, locally advanced, and advanced breast cancer (update)
Draft guidance consultation
NICE guideline
23 September 2024
Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]
Draft guidance
Technology appraisal guidance
20 September 2024
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907]
Draft guidance
Technology appraisal guidance
19 September 2024
Current page
1
2
Page
1
of
2
Next page
Results per page
10
25
50
All
Back to top